![](/img/cover-not-exists.png)
Pharmacokinetics and Pharmacodynamics of the SGLT2 Inhibitor Remogliflozin Etabonate in Subjects with Mild and Moderate Renal Impairment
O'Connor-Semmes, R., Walker, S., Kapur, A., Hussey, E. K., Ye, J., Wang-Smith, L., Tao, W., Dobbins, R. L., Cheatham, B., Wilkison, W. O.Volume:
43
Language:
english
Journal:
Drug Metabolism and Disposition
DOI:
10.1124/dmd.114.062828
Date:
May, 2015
File:
PDF, 416 KB
english, 2015